|
⚲
|
| Keyboard |
| Aisling Capital Partners LP
✚
|
|
|---|---|
| CIK # | 0001376171, 0001376172 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001376171] | |
| 4 | [0001376171] | |
| 3 | [0001376172] | |
| 4 | [0001376172] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Esperion Therapeutics Inc ESPR
Common Stock
|
2015-04-24 | Sell | 61,726 | $106.10 | 6,549,129 |
|
Esperion Therapeutics Inc ESPR
Common Stock
|
2015-04-24 | Sell | 5,743 | $108.00 | 620,244 |
|
Esperion Therapeutics Inc ESPR
Common Stock
|
2015-04-23 | Sell | 150,000 | $109.10 | 16,365,000 |
|
ADMA Biologics Inc ADMA
Common Stock
|
2013-10-22 | Buy | 411,765 | $8.50 | 3,500,002 |
|
Esperion Therapeutics Inc ESPR
Series A Preferred Stock · derivative
|
2013-07-01 | Conversion | 1,816,475 | $0.00 | |
|
Esperion Therapeutics Inc ESPR
Warrant to Purchase Preferred Stock · derivative
|
2013-07-01 | Other | 497,666 | $0.00 | |
|
Esperion Therapeutics Inc ESPR
Common Stock
|
2013-07-01 | Conversion | 1,816,475 | ||
|
Esperion Therapeutics Inc ESPR
Common Stock
|
2013-07-01 | Buy | 238,119 | $14.00 | 3,333,666 |
|
Esperion Therapeutics Inc ESPR
Warrant to Purchase Common Stock · derivative
|
2013-07-01 | Other | 71,237 | $0.00 | |
|
Melinta Therapeutics Inc /New/ CEMP
Common Stock
|
2012-02-07 | Buy | 1,213,663 | $6.00 | 7,281,978 |